Autor: admin


  • IRAD mayo 4, 2026

    CRIS Excellence

    Other research grants CRIS Cancer Foundation: 2025 CRIS Excellence Programme Grant programme aimed at promoting translational and clinical projects led by physician researchers. Application period14 May 2025 CRIS Cancer offers 2 grants as part of the CRIS Excellence Programme. This programme offers grants for between 3 and 5 years. CRIS Cancer strategy is to promote […]
    Leer más
  • IRAD mayo 4, 2026

    CRIS Emerging Leader

    Other research grants CRIS Cancer Foundation: 2025 CRIS Emerging Leader Programme Programme aimed at awarding two research grants for the incorporation of researchers into institutions in Spain. Application period14 May 2025 CRIS Cancer runs a programme to award 2 research grants as part of the CRIS Emerging Leader Programme, each covering a five-year period, for […]
    Leer más
  • IRAD mayo 4, 2026

    Cancer Research UK

    Other research grants Cancer Grand Challenges 2025 Open call for international research groups aimed at addressing major challenges in cancer research. Application submissionUntil 18 June 2025 Funding amountMaximum $25,000,000/challenge Open call for international research groups capable of addressing the seven major cancer research challenges identified in the call. More information Documentation Your browser does not […]
    Leer más
  • IRAD mayo 4, 2026

    III CONVOCATORIA BECAS IRAD-FEOR JOHNSON & JOHNSON

    La necesidad de mejorar las capacidades de investigación de los socios que componen nuestra sociedad, así como las dificultades inherentes a la obtención de fondos para aquellos que quieren comenzar una carrera profesional relacionada con la investigación, limitan en gran medida un adecuado posicionamiento de la Oncología Radioterápica en el concierto nacional e internacional de investigación.
    Leer más
  • IRAD mayo 4, 2026

    3rd IRAD-FEOR Johnson & Johnson Grants Call

    Call context The need to improve the research capabilities of the members of our society, as well as the inherent difficulties in obtaining funds for those who wish to start a professional career related to research, greatly limit the proper positioning of Radiation Oncology within the national and international research landscape. FEOR, the Spanish Foundation […]
    Leer más
  • IRAD mayo 4, 2026

    START-MET HS Prostate Cancer

    START-MET HS Prostate Cancer SbrT & Androgen Receptor Therapy METastatic HSPC Phase III Study of Stereotactic Body Radiation Therapy (SBRT) Plus Standard of Care in Castration Sensitive Oligometastatic Prostate Cancer Patients. NCT Number: NCT05209243 Estado: Reclutando Tipo de estudio: Intervencional Participantes: 266 Ficha del estudio Título breve START-MET HS Prostate Cancer. : SbrT & Androgen […]
    Leer más
  • IRAD mayo 4, 2026

    URONCOR 06-24

    URONCOR 06-24 Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer Short Versus Long-term Androgen Deprivation Therapy Combined With Salvage Radiotherapy in Prostate Cancer Patients With Biochemical Recurrence After Prostatectomy: a Multicentre Phase III Randomised Controlled Trial. NCT NumberNCT05781217 EstadoRecruiting Tipo de estudioInterventional FasePhase 3 Participantes534 Ficha del estudio Título breve Short […]
    Leer más
  • IRAD abril 28, 2026

    Sobre el dictamen único para estudios observacionales sin medicamentos, multicéntricos

    Documentación IRAD-FEOR Dictamen único en estudios observacionales multicéntricos sin medicamentos Documento relacionado con la reevaluación de estudios observacionales multicéntricos sin medicamentos que ya cuentan con dictamen positivo de un CEI. Descripción del problema En estudios observacionales sin medicamentos, multicéntricos, es frecuente que muchos centros participantes obliguen a reevaluar estudios que ya tienen un dictamen positivo […]
    Leer más
  • IRAD abril 28, 2026

    On the single opinion for multicentre non-drug observational studies

    IRAD-FEOR documentation Single opinion in multicentre non-drug observational studies Document related to the reassessment of multicentre non-drug observational studies that already have a positive opinion from an IEC. Problem description In multicentre non-drug observational studies, it is common for many participating centres to require reassessment of studies that already have a positive opinion from an […]
    Leer más